Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Licaminlimab in Dry Eye Disease
NCT07548632Phase 3Active, not recruiting
- Sponsor
- Oculis
- Start
- Apr 2026
- Primary completion
- Dec 2026
- Modality
- scFv Fragments
- Countries
- 1
01
Overview
A Phase 3 trial of licaminlimab in dry eye disease (DED), sponsored by Oculis. Started Apr 2026; status: active, not recruiting.
02
Drugs
licaminlimab
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07548632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07548632.